Nadofaragene firadenovec is the first and only non-replicating gene therapy administered intravesically, and it is already approved and launched in the US This represents the first filing ...

England’s goal to eradicate bovine tuberculosis (TB) by 2038 remains alive – but only just. In the past decade, 274,000 ...

New York | Boston Consulting Group will train its staff in “humanitarian principles” and impose extra oversight on sensitive projects, following an outcry over its work on a proposal to relocate ...

The Middle East and Africa (MEA) space market is valued at $18 billion, according to a new report from Boston Consulting Group (BCG) titled “Governments in Space: A universe of opportunities”. The UAE ...

The Middle East and Africa (MEA) space market is valued at $18bn, with the UAE holding a 40-45 per cent market share, according to a new report from Boston Consulting Group (BCG) titled Governments in ...

CytomX pivots to CX-2051 in colorectal cancer with early efficacy, GI toxicity concerns, and strong cash runway into 2027.

Binah Capital Group, Inc., together with its subsidiaries, operates in the wealth management industry. The company provides access to stock, bond, exchange-traded fund, and options execution services; ...

Every time Jennifer publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

Myc dysregulation in activated macrophages impairs antioxidant defenses, locking them in a vicious cycle that amplifies type I interferon signaling, driving hyperinflammation and immunosuppression.

By: Fabrizio Dell'Acqua, Edward McFowland III, Ethan Mollick, Hila Lifshitz-Assaf, Katherine C. Kellogg, Saran Rajendran, Lisa Krayer, François Candelon and Karim R. Lakhani ...